文献速递脑血管病认知障碍与痴呆

高敏心肌肌钙蛋白T与缺血性卒中患者认知功能

High-Sensitivity Cardiac Troponin T and Cognitive Function in Patients With Ischemic Stroke.
PubMed 文献 · Stroke · 2020-04-13

本研究基于PROSCIS-B前瞻性队列,纳入555例轻中度首次缺血性卒中患者,评估高敏心肌肌钙蛋白T(hs-cTnT)与认知功能的关系。结果显示,hs-cTnT最高四分位组基线认知障碍风险比最低组升高(调整RR 1.76,95%CI 1.07-2.90),随访期电话认知状态改良评分持续较低(调整β -1.33,95%CI -2.65至-0.02),但认知变化速率无差异。

要点

  • 轻中度首次缺血性卒中患者中,基线hs-cTnT升高与认知障碍患病率增加相关。
  • hs-cTnT最高四分位组随访期电话认知状态改良评分较低,但认知变化速率无差异。
  • hs-cTnT或可作为卒中后认知障碍风险评估的参考指标。

核心结论

  • 在无痴呆的轻中度首次缺血性卒中患者中,较高的hs-cTnT与基线认知障碍患病率较高及3年随访期电话认知状态改良评分较低相关。

研究设计与样本

  • 基于PROSCIS-B前瞻性队列,纳入555例轻中度首次缺血性卒中患者,平均年龄67岁,62%男性,中位NIHSS 2分(IQR 1-5),40%患者hs-cTnT高于参考上限,基线认知障碍占28%。

主要发现

  • hs-cTnT最高四分位组与最低四分位组相比,基线简易精神状态检查中位评分27 vs 29,认知障碍比例15.3% vs 43.0%,调整风险比1.76(95%CI 1.07-2.90)。
  • 随访期电话认知状态改良评分在hs-cTnT最高四分位组持续较低,调整β -1.33(95%CI -2.65至-0.02),但认知变化速率无差异。

关键数值与推荐

  • 认知障碍定义:基线简易精神状态检查<27分,随访电话认知状态改良评分<32分。

临床怎么用

  • 对轻中度首次缺血性卒中患者,检测hs-cTnT可能有助于识别基线认知障碍高风险者,但需进一步验证其临床效用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Our study aim was to assess whether high-sensitivity cardiac troponin T (hs-cTnT), a specific biomarker for myocardial injury, is associated with cognitive function in patients after mild-to-moderate first-ever ischemic stroke. Methods- We used data from PROSCIS-B (Prospective Cohort With Incident Stroke Berlin). Cognitive function was assessed by Mini-Mental-State-Examination at baseline, and Telephone Interview for Cognitive Status-modified after 1 to 3 years of follow-up. Patients were categorized according to hs-cTnT quartiles. We performed generalized linear regression to calculate risk ratios of cognitive impairment (Mini-Mental-State-Examination <27; Telephone Interview for Cognitive Status-modified <32). Association of hs-cTnT with cognitive function over time was estimated using a linear mixed model. Results- We included 555 patients (mean age, 67 years, 62% male, median National Institutes of Health Stroke Scale 2 [interquartile range, 1-5], hs-cTnT above upper reference limit 40%, baseline cognitive impairment 28%). Baseline Mini-Mental-State-Examination score and rate of cognitive impairment were lower in patients in the highest versus lowest hs-cTnT quartile (median Mini-Mental-State-Examination 27 versus 29, and 15.3% versus 43.0%, adjusted risk ratio, 1.76 [95% CI, 1.07-2.90], respectively). If anything, cognition seemed to improve in all groups, yet Telephone Interview for Cognitive Status-modified scores were consistently lower in patients within the highest versus lowest hs-cTnT quartile (adjusted β, -1.33 [95% CI, -2.65 to -0.02]), without difference in the rate of change over time. Conclusions- In patients with mild-to-moderate first-ever ischemic stroke without dementia, higher hs-cTnT was associated with higher prevalence of cognitive impairment at baseline and lower Telephone Interview for Cognitive Status-modified during 3-year follow-up. Registration- URL: https://www.clinicaltrials.gov; Unique identifier: NCT01363856.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Broersen LHA, Siegerink B, Sperber PS, et al. High-Sensitivity Cardiac Troponin T and Cognitive Function in Patients With Ischemic Stroke. Stroke. 2020. PMID: 32279621. doi:10.1161/STROKEAHA.119.028410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。